Pharmacy

In this Becker’s Healthcare sponsored webinar, Visante hosts a peer discussion with leaders from Dartmouth Health on how alignment between the Chief Financial Officer and Chief Pharmacy Officer strengthens decision-making, improves visibility into medication cost and revenue, and drives stronger…

Starting specialty therapy can involve navigating as many as nine separate platforms.For health systems, medical centers and hospital pharmacies, that fragmentation slows treatment initiation and complicates coordination across stakeholders. In oncology, even small delays can carry significant clinical and operational…

Pharmacy procurement is no longer just about purchasing medications. Rising drug costs, persistent shortages, limited staffing and growing 340B complexity are forcing pharmacy leaders into broader financial and operational decisions, often without connected data or workflows to support them. In…

Pharmacy operations have shifted from a departmental function to a board-level priority as margin pressure and compliance exposure intensify across health systems. Yet many organizations still operate with fragmented procurement models and legacy oversight approaches that limit control and visibility.…

Specialty drug growth is accelerating, but billing infrastructure has not kept pace. High-cost therapies now represent a growing share of total drug spend and pipeline volume. At the same time, medical benefit claims, prior authorizations, payer policy changes and 340B…

Specialty pharmacies face growing pressure to improve efficiency, but legacy workflows often stand in the way — creating delays and headaches. This session explores how leaders are replacing manual processes with flexible, tech-enabled systems that accelerate care and ease day-to-day…

The care delivery journey for Cardiology specialty disease patient populations is evolving rapidly. As they seek to optimize patient outcomes and health system priorities, executive leaders at health systems are pioneering novel multi-disciplinary approaches. A recent Becker’s-Alnylam survey of 101 senior…

A vital program to the survival of the country’s most vulnerable hospitals has announced a change that could significantly impact eligible hospitals. For more than 30 years, the 340B Drug Pricing Program has been an upfront discount model to hospitals…

Drug shortages are no longer isolated events. They’re routine, costly — and deeply disruptive to patient care, pharmacy workflows and operating margins. But reacting in real time only goes so far. Without a predictive strategy, emergency buys and missed formulary…